The rapidly evolving coronavirus pandemic is a public health crisis. It has highlighted both the powerful spirit of partnership to respond and the fragmented nature of healthcare today. In this special episode we’re sharing our initial observations and reflections including how the pandemic may impact the future of the healthcare industry.
Discover how pharmaceutical companies can enhance patient experience and interoperability through direct-to-patient (DTP) models.
Read moreLaunchNav by Inizio simplifies pharma launches with AI-driven insights, real-time benchmarks, and 800+ launch learnings.
Read moreOBBBA reshapes U.S. healthcare with $1.2T cuts, shifting risk to providers, payers, and pharma. Explore impacts and strategies.
Read more